Relatório global de análise do tamanho, quota e tendências do mercado da canábis medicinal – Visão geral do setor e previsão para 2031

Análise do mercado da canábis medicinal

O mercado da canábis medicinal está a experimentar um crescimento significativo impulsionado pelos avanços nas técnicas e tecnologia de cultivo. Uma inovação notável é a utilização de tecnologia de agricultura de precisão , incluindo sistemas automatizados para monitorizar e otimizar o crescimento das plantas. Estes sistemas utilizam sensores e análise de dados para rastrear variáveis ​​como a luz, a humidade e as condições do solo , levando ao aumento do rendimento e à consistência na qualidade do produto. Além disso, os avanços na tecnologia de extração, como a extração de CO2 e etanol, melhoraram a pureza e a potência dos produtos de canábis medicinal.

A ascensão da medicina personalizada está também a contribuir para o crescimento do mercado, à medida que os doentes e os prestadores de cuidados de saúde procuram cada vez mais terapias canabinóides personalizadas para condições médicas específicas. As inovações nos sistemas de administração de canabinóides, tais como os adesivos transdérmicos e as formulações baseadas em nanotecnologia, estão a melhorar a eficácia e a conveniência dos tratamentos. A integração de plataformas de telemedicina está a alargar o acesso à canábis medicinal, permitindo consultas e prescrições virtuais, o que impulsiona ainda mais a expansão do mercado. No geral, estes avanços tecnológicos estão a abrir caminho para uma indústria de marijuana medicinal mais eficaz e acessível.

Tamanho do mercado de canábis medicinal

O tamanho do mercado global de canábis medicinal foi avaliado em 28,03 mil milhões de dólares em 2023 e deverá atingir os 104,73 mil milhões de dólares até 2031, com um CAGR de 17,91% durante o período de previsão de 2024 a 2031. Além dos insights sobre os cenários de mercado, como o valor de mercado, a taxa de crescimento, a segmentação, a cobertura geográfica e os grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também a análise especializada aprofundada, a epidemiologia dos doentes, a análise de pipeline, a análise de preços e a estrutura regulatória.

Tendências do mercado da canábis medicinal

“Crescente aceitação da canábis medicinal para o tratamento da dor crónica”

Uma tendência chave que impulsiona o mercado da canábis medicinal é a sua crescente aceitação no tratamento da dor crónica. Os doentes e os profissionais de saúde reconhecem cada vez mais a eficácia da canábis medicinal no alívio da dor crónica onde os tratamentos tradicionais têm sido ineficazes ou apresentam efeitos secundários adversos. Por exemplo, estudos que mostram os efeitos positivos dos canabinoides na dor neuropática levaram à expansão da aprovação da canábis medicinal em várias regiões. A legalização e a integração da canábis medicinal nos protocolos de gestão da dor, apoiadas pela evolução da legislação e da investigação médica, estão a impulsionar o crescimento do mercado. Esta tendência sublinha a mudança para opções de tratamento holísticas e menos invasivas nos cuidados de saúde.

Âmbito do relatório e segmentação do mercado de canábis medicinal 

Medical Marijuana Market Definition

Medical marijuana refers to the use of the cannabis plant or its compounds for therapeutic purposes. It involves the use of cannabis or its derivatives, such as cannabinoids, to alleviate symptoms or manage chronic conditions. Medical marijuana is prescribed by healthcare professionals to treat various ailments, including chronic pain, nausea, epilepsy, and multiple sclerosis. It can be administered in various forms, including oils, tinctures, edibles, and vaporizers. Its effectiveness and legality vary by region, with some places allowing its use for specific medical conditions and others only for research purposes.

Medical Marijuana Market Dynamics

Drivers

• Growing Telemedicine Integration

The rise of telemedicine significantly drives the medical marijuana market by enhancing access to consultations and prescriptions, especially in remote or underserved areas. For instance, platforms such as "TeleLeaf" enable patients to consult with licensed medical professionals and receive prescriptions for medical marijuana from the comfort of their homes. This convenience addresses geographical and logistical barriers, expanding patient reach and increasing adoption rates. As telemedicine continues to grow, it facilitates more widespread use of medical marijuana, contributing to market growth.

• Rising Chronic Disease Prevalence

The rising prevalence of chronic diseases such as cancer, arthritis, and multiple sclerosis significantly drives the medical marijuana market. For instance, in the U.S., the National Cancer Institute highlights that medical marijuana can help alleviate symptoms associated with cancer treatments, such as nausea and pain. Similarly, patients with arthritis and multiple sclerosis use medical cannabis for its anti-inflammatory and pain-relief properties. As these conditions become more common, the demand for alternative treatments such as medical marijuana grows, expanding the market and encouraging further research and development.

Opportunities

• Increased Acceptance of Medical Marijuana

Increased acceptance of medical marijuana has opened significant market opportunities. As more healthcare professionals recognize its therapeutic benefits, such as pain relief for cancer patients and reducing seizures in epilepsy, the demand for medical marijuana grows. For instance, the approval of Epidiolex, a cannabis-derived drug for epilepsy, has highlighted its medical potential, encouraging further research and adoption. This shift not only drives patient interest but also attracts investment in product development, regulatory advancements, and market expansion, creating a robust growth trajectory for the medical marijuana market.

• Shift Towards Personalized Medicine

The shift towards personalized medicine presents a significant opportunity in the medical marijuana market. As healthcare moves towards customized treatments, medical marijuana's ability to offer tailored solutions for various conditions becomes increasingly valuable. For instance, in cases such as chronic pain management, strains of medical marijuana can be specifically chosen based on an individual’s genetic profile and response to treatment. This approach not only improves patient outcomes but also drives demand for specialized medical marijuana products, creating growth opportunities for companies focusing on personalized therapeutic solutions.

Restraints/Challenges

• High Price of Raw Material

The high costs associated with medical marijuana, including production, quality control, and distribution, can make it less accessible to patients. This pricing issue limits market penetration and reduces patient reach. The financial burden of producing high-quality medical marijuana and ensuring its consistent availability impacts affordability and accessibility, hindering the market's growth and development. Additionally, the expensive nature of medical marijuana contributes to slower adoption rates and less widespread use among those who may benefit from its therapeutic properties.   

• Stigma and Social Acceptance

Social stigma surrounding marijuana use can significantly deter potential patients and healthcare professionals from embracing medical marijuana. This cultural resistance, rooted in historical perceptions and societal biases, often results in reluctance to consider or recommend medical marijuana as a treatment option. The negative connotations associated with marijuana can affect its acceptance in mainstream healthcare practices, hindering its adoption and limiting market growth. This stigma impedes progress by restricting broader societal and medical acceptance, thereby affecting market potential and expansion.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Medical Marijuana Market Scope

The market is segmented on the basis of form, product type, active ingredient, type, application, route of administration, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Form

• Solid
• Gas
• Dissolvable/Powders

 Product Type

• Buds
• Oils
• Tinctures
• Others

 Active Ingredient

• Tetrahydrocannabinol (THC)
• Cannabidiol (CBD)

 Type

• Flowers
• Concentrates
• Edibles
• Others

 Application

• Chronic Pain
• Arthritis
• Cancer
• Neurology
• Oncology
• Others
  • Migraine
  • Seizures

 Route of Administration

• Inhalation
• Oral
• Topical

Distribution Channel

• Retail and Pharmacy Stores
• Online Platforms

Medical Marijuana Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, form, product type, active ingredient, type, application, route of administration, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

North America is expected to dominate the medical marijuana market, with the U.S. leading due to rising product usage across various medical applications and the legalization of cannabis. This trend reflects growing acceptance and expanding therapeutic uses, positioning the U.S. as a key player in shaping the region's medical marijuana landscape.

Asia-Pacific is expected to grow at the highest growth rate in the medical marijuana market during the forecast period. This surge is driven by the rising popularity of various medical marijuana products, including creams, lotions, gels, and ointments. Increased awareness and evolving regulations are further boosting the market's expansion in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Medical Marijuana Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Medical Marijuana Market Leaders Operating in the Market Are:

• Canopy Growth Corporation (Canada)
• Cannabis Sativa, Inc. (U.S.)
• GW Pharmaceuticals plc (U.K.)
• Emerald Health Therapeutics Inc. (Canada)
• Tilray (Canada)
• Aphria Inc. (Canada)
• Aurora Cannabis (Canada)
• Cara Therapeutics, Inc. (U.S.)
• Medical Marijuana, Inc. (U.S.)
• Pfizer Inc. (U.S.)
• GB Sciences, Inc. (U.S.)
• MediPharm Labs Corp. (Canada)
• MedReleaf Australia (Australia)
• Green Relief Inc. (Canada)
• Peace Naturals Project Inc. (Canada)
• VIVO Cannabis Inc. (Canada)
• The Cronos Group (Canada)
• United Cannabis (U.S.)

Latest Developments in Medical Marijuana Market

• In March 2024, Jesse Ventura launched a new cannabis edible brand in collaboration with Retro Bakery, located in Columbia Heights. This partnership focuses on producing THC-infused edibles derived from hemp, aiming to cater to the growing market for cannabis products. The venture highlights Ventura's entry into the expanding cannabis industry with innovative offerings
• In February 2023, Metrc expanded its contract with the State of Missouri to enhance the regulatory framework for its adult-use marijuana market. This extension aims to provide advanced tracking and compliance solutions, ensuring efficient oversight and transparency in the state’s growing cannabis sector, and supporting its regulatory and operational needs
• Em abril de 2022, a Medi Cane Health Inc. e a Dr. Reddy's Laboratories Ltd. lançaram um novo produto de canábis medicinal na Alemanha. Esta colaboração marca um avanço significativo no mercado europeu da canábis medicinal, combinando a experiência da Medi Cane com as capacidades farmacêuticas do Dr. Reddy para oferecer opções de tratamento inovadoras aos doentes
• Em abril de 2022, a cidade de Nova Iorque testemunhou as suas primeiras vendas legais de canábis um mês após ter recebido a aprovação para que sete empresas de canábis medicinal começassem a vender a adultos. Este marco marcou uma expansão significativa do mercado de canábis de Nova Iorque, passando das vendas medicinais para as recreativas e refletindo a posição progressista do estado em relação à legalização da canábis.

SKU-58793